Perhaps a bit of a stand off here atm!
Will the market see value from here at $15 range, a recent high from Trof/Daybue's progress earlier this year.
Or will it see Neu is currently undervalued on Trof/Daybues own merits and add value with anticipation of upcoming results in Dec from PMS in 2591 a drug that has initially x 5 market value as Trof/Daybue.
Haven't really had a breakout of significance yet, which way will it go?
Are we going to stay in this range and bounce around $15 until read out, or will it be pushed lower to scare punters, shake out last few shares?
Share Price, page-7997
-
- There are more pages in this discussion • 4,146 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.05 |
Change
-0.510(3.50%) |
Mkt cap ! $1.795B | |||
| Open | High | Low | Value | Volume |
| $14.38 | $14.42 | $13.94 | $6.419M | 454.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $13.99 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.07 | 6644 | 4 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |